Chronic Obstructive Pulmonary Disease (COPD) is often seen as an older man’s disease, but the reality is changing. Today, more women, non-smokers, and even younger adults are being diagnosed with COPD than ever before. As the face of this condition shifts, the need for early detection and better treatments has never been more urgent.
The problem? Many people still don’t know what to look for. Early signs of COPD are frequently dismissed as normal ageing or simply being out of shape, leaving the disease to go undiagnosed until it’s too late. This article explores why these early warning signs are often overlooked, the gender-specific challenges women face, and the promising new treatments that are changing the outlook for COPD patients everywhere.
The expanding scope of COPD: Moving beyond smoking
While smoking remains the leading cause of COPD, emerging research highlights other significant risk factors, including air pollution, indoor smoke, and genetic predispositions. The World Health Organization (WHO) reports that COPD causes 3 million deaths annually, making it the third leading cause of death worldwide (2020). In particular, fine particulate matter (PM2.5) from urban environments and biomass fuels used for cooking in low-income regions remain major contributors to COPD risk, especially for women and children who are more exposed to indoor pollution.
These environmental factors also emphasise the importance of early recognition and early intervention. If COPD is detected early, effective treatment can slow progression and improve quality of life. However, many individuals fail to recognise the symptoms of COPD, often dismissing them as normal signs of ageing or poor fitness.
As explained by Assoc Prof Dr Pang, a Respiratory Physician, “The subtle early symptoms of COPD include shortness of breath during exertion and a chronic cough. In the early stages, shortness of breath may occur during strenuous activities like running or climbing stairs. As the disease progresses, shortness of breath may be felt during less demanding tasks, such as walking or carrying groceries.”
COPD in women: Unique challenges and opportunities
As COPD becomes more common in women, understanding the specific challenges they face is essential. Studies have shown that women with COPD often experience faster disease progression, particularly after menopause, partly due to the decline in oestrogen. Oestrogen has protective effects on lung health, and its reduction after menopause may contribute to the accelerated decline in lung function observed in women. Additionally, women are more likely to be misdiagnosed with asthma, which can delay a COPD diagnosis, leading to more severe disease progression over time.
This gap in diagnosis and treatment presents a critical issue in COPD care. Gender-specific research is essential to understanding how COPD affects women differently and improving both diagnostic accuracy and treatment protocols tailored to their needs. Studies suggest that symptoms, disease progression, and responses to treatments in women may differ significantly from those in men, highlighting the importance of personalised care to ensure women with COPD receive the most effective management strategies.
Opportunities to improve care for women with COPD
Given the gender-specific challenges women face, there are numerous opportunities to improve their care, from increasing awareness to tailoring treatments to meet their unique needs.
Raising awareness about COPD in women is essential. Public health campaigns focusing on symptoms, risk factors, and early detection can help women recognise symptoms earlier and seek treatment before the disease progresses.
Understanding how oestrogen influences COPD can lead to the development of gender-specific treatments that cater to the unique needs of women, especially postmenopausal women, slowing disease progression and improving their quality of life.
More gender-specific research is needed to explore how COPD affects women differently. Understanding hormonal fluctuations and the impact of gender on disease progression will improve diagnostic tools and treatment protocols.
Pulmonary rehabilitation, which combines exercise, education, and mental health support, has proven to improve the quality of life for COPD patients. These programs should be tailored to meet the specific needs of women, including addressing caregiving responsibilities and emotional support, to increase their effectiveness.
Governments can improve environmental conditions by implementing policies to reduce air pollution, provide cleaner cooking technologies, and ensure smoke-free environments. Public health campaigns targeting women, particularly in developing regions, can reduce exposure to harmful pollutants and prevent or delay the onset of COPD.
The horizon: What’s next for COPD?
With advancements in early diagnosis, personalised treatments, and emerging technologies, the future of COPD care is evolving. Gene therapy, stem cell research, and personalised medicine are opening the door to groundbreaking treatments that may one day repair damaged lung tissue and stop the progression of COPD.
Additionally, smart inhalers and telemedicine are transforming patient care, making it easier for patients to monitor their condition remotely and receive care in real-time. Despite these innovations, patient education remains essential for improving long-term outcomes. By learning to recognise early signs, make lifestyle changes, and seek timely treatment, individuals can significantly improve their long-term outcomes.
“For individuals newly diagnosed with COPD, the first step in managing COPD is smoking cessation. Avoiding exposure to harmful fumes or gases is equally important. For symptom management, practicing pursed-lip breathing during exercise can help with shortness of breath. Regular aerobic activity, such as brisk walking for 30 minutes a day, can improve stamina and overall lung health,” Assoc Prof Dr Pang suggests.
COPD’s global impact: Why it matters more than ever
COPD is a growing global health crisis, with its prevalence increasing due to rising air pollution, smoking rates, and ageing populations. According to the American Lung Association, the disease costs the U.S. healthcare system more than $50 billion annually, highlighting the economic burden COPD places on healthcare systems worldwide.
The global impact of COPD further emphasises the importance of early intervention and patient education. By addressing early detection, prevention, and treatment advances, we can significantly improve the quality of life for those with COPD and reduce the strain on healthcare systems.
For individuals with symptomatic COPD, the mainstay of treatment involves inhaled long-acting bronchodilators. To achieve the best effect, a combination of bronchodilators from two different classes, long-acting beta2 agonists and long-acting antimuscarinics, is typically used. In cases where a patient experiences frequent acute flare-ups and has a high eosinophil count (a higher-than-normal number of a specific type of white blood cell, often linked to inflammation), inhaled corticosteroids may be added to the dual bronchodilator regimen.
Additionally, if the disease remains suboptimally controlled, certain oral medications can also be considered. For individuals who experience significant desaturation (a drop in oxygen levels in the blood) during daily activities or at rest, long-term oxygen therapy may be prescribed to ease breathing and improve oxygen levels.
The outlook for individuals living with COPD has significantly improved in recent years due to advancements in clinical treatments and ongoing research. With the right medical management, the quality of life for those living with the condition can be substantially enhanced.
If you have a history of smoking or a family history of respiratory issues, taking proactive steps can potentially prevent or delay the onset of COPD. As suggested by Assoc Prof Dr Pang, the most effective measure is to quit smoking or vaping and avoid exposure to harmful fumes or gases. Even for those already diagnosed with COPD, smoking cessation can significantly slow the progression of the disease.
COPD is no longer a disease of the past; it is a growing health concern that affects millions today. As the condition increasingly affects women, non-smokers, and younger adults, it’s critical to understand what’s changing and why early detection is so important.
With early intervention, lifestyle changes, and advancements in treatment, the outlook for those with COPD can be greatly improved. If you’re at risk, it’s never too early to take proactive steps toward better lung health.
Assoc Prof Dr Pang Yong Kek
Senior Consultant Respiratory Physician
Faculty of Medicine, University of Malaya, Malaysia
This article was produced by Healthful For You. The views and opinions expressed throughout are those of the authors and do not necessarily reflect those of the Expert Contributor. The Expert Contributor has provided input solely for the EXPERT INSIGHT and TIP segments, based on their professional expertise. These comments are intended to offer general guidance and may not apply to all individuals. Any interpretations or conclusions beyond that section are those of Healthful For You. This article is not a substitute for personalised medical advice, diagnosis, or treatment. Please consult your doctor or a healthcare professional regarding your specific health needs.
We hope you found this article informative. Healthful For You welcomes contributions from healthcare professionals, patients, and community members. If you have a story, research, or a perspective that can enrich our dialogue, please get in touch with us at [email protected].